Activated protein c rescues the retina from ischemia-induced cell death

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 2, 2011, Pages 987-993

  Du, Zhao Jiang ^a   Yamamoto, Takuhiro ^a,b   Ueda, Tomoko ^a   Suzuki, Mihoko ^a   Tano, Yasuo ^a   Kamei, Motohiro ^a  

^a OSAKA UNIVERSITY   (Japan)

^b Meiwa Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; CASPASE 3; CASPASE 8; CASPASE 9; FIBRINOLYTIC AGENT; PROTEIN C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DEATH; CELL HYPOXIA; CELL PROTECTION; CENTRAL RETINA VEIN OCCLUSION; CONTROLLED STUDY; CYTOTOXICITY; NONHUMAN; PHOTORECEPTOR CELL; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RAT; RETINA ISCHEMIA; ANIMAL; ANOXIA; CELL CULTURE; CELL SURVIVAL; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; ENZYMOLOGY; HUMAN; INTRAVITREAL DRUG ADMINISTRATION; METABOLISM; MOUSE; NICK END LABELING; PATHOLOGY; REPERFUSION INJURY; RETINA CONE; RETINA VEIN OCCLUSION; TRANSGENIC MOUSE;

ANIMALS; ANOXIA; APOPTOSIS; CASPASE 3; CASPASE 8; CASPASE 9; CELL SURVIVAL; CELLS, CULTURED; CYTOPROTECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBRINOLYTIC AGENTS; HUMANS; IN SITU NICK-END LABELING; INTRAVITREAL INJECTIONS; MICE; MICE, TRANSGENIC; PROTEIN C; RATS; REPERFUSION INJURY; RETINAL CONE PHOTORECEPTOR CELLS; RETINAL PIGMENT EPITHELIUM; RETINAL VEIN OCCLUSION;

EID: 79953292553     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-5557     Document Type: Article

References (26)

1. Osborne NN, Casson RJ, Wood JP, Chidlow G, Graham M, Melena J. Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res. 2004;23:91-147.
2. Griffin JH, Fernández JA, Liu D, Cheng T, Guo H, Zlokovic BV. Activated protein C and ischemic stroke. Crit Care Med. 2004;32: S247-53.
3. Cheng T, Liu D, Griffin JH, et al. Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective. Nat Med. 2003;9:338-342.
4. Cheng T, Petraglia AL, Li Z, et al. Activated protein C inhibits tissue plasminogen activator-induced brain hemorrhage. Nat Med. 2006; 12:1278-1285.
5. Guo H, Liu D, Gelbard H, et al. Activated protein C prevents neuronal apoptosis via protease activated receptors 1 and 3. Neuron. 2004;19(41):563-572.
6. Joyce DE, Gelbert L, Ciaccia A, DeHoff B, Grinnell BW. Gene expression profile of antithrombotic protein c defines new mechanisms modulating inflammation and apoptosis. J Biol Chem. 2001; 276:11199-11203.
7. Liu D, Cheng T, Guo H, et al. Tissue plasminogen activator neuro-vascular toxicity is controlled by activated protein C. Nat Med. 2004;10:1379-1383.
8. Riewald M, Petrovan RJ, Donner A, Mueller BM, Ruf W. Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science. 2002;296:1880-1882.
9. Bartolome S, Wood JG, Casillan AJ, Simpson SQ, O'Brien-Ladner AR. Activated protein C attenuates microvascular injury during systemic hypoxia. Shock. 2008;29:384-387.
10. Gierer P, Hoffmann JN, Mahr F, et al. Activated protein C reduces tissue hypoxia, inflammation, and apoptosis in traumatized skeletal muscle during endotoxemia. Crit Care Med. 2007;35:1966-1971.
11. Tan E, Ding XQ, Saadi A, Agarwal N, Naash MI, Al-Ubaidi MR. Expression of cone-photoreceptor-specific antigens in a cell line derived from retinal tumors in transgenic mice. Invest Ophthalmol Vis Sci. 2004 Mar;45(3):764-768.
12. Royster AJ, Nanda SK, Hatchell DL, Tiedeman JS, Dutton JJ, Hatch-ell MC. Photochemical initiation of thrombosis: fluorescein angio-graphic, histologic, and ultrastructural alterations in the choroid, retinal pigment epithelium, and retina. Arch Ophthalmol. 1988; 106:1608-1614.
13. Yamamoto T, Kamei M, Kunavisarut P, Suzuki M, Tano Y. Increased retinal toxicity of intravitreal tissue plasminogen activator in a central retinal vein occlusion model. Graefes Arch Clin Exp Ophthalmol. 2008;246:509-514.
14. Dureau P, Bonnel S, Menasche M, Dufier JL, Abitbol M. Quantitative analysis of intravitreal injections in the rat. Curr Eye Res. 2001;22:74-77.
15. Campochiaro PA. Retinal and choroidal neovascularization. J Cell Physiol. 2000;184:301-310.
16. Shibata M, Kumar SR, Amar A, et al. Anti-inflammatory, antithrombotic, and neuroprotective effects of activated protein C in a murine model of focal ischemic stroke. Circulation. 2001;103: 1799-1805.
17. Isermann B, Vinnikov IA, Madhusudhan T, et al. Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis. Nat Med. 2007;13:1349-1358.
18. Bi FF, Xiao B, Hu YQ, et al. Expression and localization of Fas-associated proteins following focal cerebral ischemia in rats. Brain Res. 2008;1191:30-38.
19. Lee SR, Lok J, Rosell A, et al. Reduction of hippocampal cell death and proteolytic responses in tissue plasminogen activator knockout mice after transient global cerebral ischemia. Neuroscience. 2007;150:50-57.
20. Liu Y, Sercombe R, Xie D, Liu K, Chen L. Inhibition of caspase-9 activation and apoptosis is involved in ischemic preconditioning-induced neuroprotection in rat brain. Neurol Res. 2007;29:855-861.
21. Shimmyo Y, Kihara T, Akaike A, Niidome T, Sugimoto H. Three distinct neuroprotective functions of myricetin against glutamate-induced neuronal cell death: involvement of direct inhibition of caspase-3. JNeurosci Res. 2008;86:1836-1845.
22. Yang P, Peairs JJ, Tano R, Zhang N, Tyrell J, Jaffe GJ. Caspase-8-mediated apoptosis in human RPE cells. Invest Ophthalmol Vis Sci. 2007;48(7):3341-3349.
23. Hiroi K, Yamamoto F, Honda Y. Intraretinal study of cat electro-retinogram during retinal ischemia-reperfusion with extracellular K+ concentration microelectrodes. Invest Ophthalmol Vis Sci. 1994;35:656-663.
24. Faude S, Faude F, Siegemund A, Wiedemann P. Activated protein C resistance in patients with central retinal vein occlusion in comparison to patients with a history of deep-vein thrombosis and a healthy control group (in German). Ophthalmologe. 1999;96(9): 594-599.
25. Graham SL, Goldberg I, Murray B, Beaumont P, Chong BH. Activated protein C resistance-low incidence in glaucomatous optic disc haemorrhage and central retinal vein occlusion. Aust N Z J Ophthalmol. 1996;24(3):199-205.
26. Johnson TM, El-Defrawy S, Hodge WG, et al. Prevalence of factor V Leiden and activated protein C resistance in central retinal vein occlusion. Retina. 2001;21(2):161-166.